Novel small molecule SIRT2 inhibitors induce cell death in leukemic cell lines
2018 · BMC Cancer · 48 citations
https://doi.org/10.1186/s12885-018-4710-1
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
24
Papers
794
Citations
17
h-index
18
i10-index
Paolo Mellini is an academic researcher from Kyoto Prefectural University of Medicine. The author has contributed to research in topics: Sirtuins and Resveratrol in Medicine & Autophagy in Disease and Therapy & PARP inhibition in cancer therapy. The author has an h-index of 17, co-authored 21 publications.
ORCID: 0000-0002-5624-7286https://doi.org/10.1186/s12885-018-4710-1
https://doi.org/10.6084/m9.figshare.c.4025029.v1
Click to start Chat